Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD) : a randomised controlled trial. (BICS)
Citation
Cotton , S , Devereux , G , Abbas , H , Briggs , A H , Campbell , K , Chaudhuri , R , Choudhury , G , Dawson , D , De Soyza , A , Fielding , S , Gompertz , S , Haughney , J , Lang , C C , Lee , A , MacLennan , G , MacNee , W , McCormack , K , McMeekin , N , Mills , N L , Morice , A , Norrie , J , Petrie , L , Price , D , Short , P , Vestbo , J , Walker , P , Wedzicha , J A , Wilson , A & Lipworth , B J 2022 , ' Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD) : a randomised controlled trial. (BICS) ' , Trials , vol. 23 , no. 1 , 307 . https://doi.org/10.1186/s13063-022-06226-8